Managers / Q1 2020 · view latest →
Silver Point Capital L.P.
CIK 0001332784 · TWO GREENWICH PLAZA, SUITE 1, GREENWICH, CT, 06830 · (203) 542-4000
Summary
Silver Point Capital L.P. reported $853M in U.S.-listed holdings across 18 positions for Q1 2020.
The portfolio is heavily concentrated: Studio City Intl alone accounts for 25.6% of reported value.
Compared with Q4 2019, the fund opened 8 new positions and exited 1.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- ETP · 39.3% · $336M
- Common Stock · 35.1% · $300M
- ADR · 25.6% · $218M
Quarter-over-Quarter Changes full breakdown →
vs Q4 2019 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| VANGUARD SCOTTSDALE FDS | NEW | +975.0K | 975.0K | +$85M | $85M |
| ISHARES TR | NEW | +418.8K | 418.8K | +$47M | $47M |
| VANGUARD SCOTTSDALE FDS | NEW | +430.0K | 430.0K | +$42M | $42M |
| SPDR SER TR | NEW | +460.0K | 460.0K | +$23M | $23M |
| INVESCO EXCHANGE-TRADED FD T | NEW | +790.3K | 790.3K | +$20M | $20M |
| PDLIEURPDL BIOPHARMA INC | NEW | +4.90M | 4.90M | +$14M | $14M |
| VANECK VECTORS ETF TR | NEW | +230.1K | 230.1K | +$11M | $11M |
| SPDR SER TR | NEW | +11.0K | 11.0K | +$333,000 | $333,000 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2020
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | STUDIO CITY INTL HLDGS LTD | SPON ADS | 25.55% | $218M | 10.80M |
| 2 | PCGPG&E CORPhistory → | COM | 25.29% | $216M | 24.01M |
| 3 | ISHARES TR | IBOXX INV CP ETF · NATIONAL MUN ETF | 15.03% | $128M | 1.07M |
| 4 | VANGUARD SCOTTSDALE FDS | INT-TERM CORP · LG-TERM COR BD | 14.84% | $127M | 1.41M |
| 5 | CZREURCAESARS ENTMT CORPhistory → | COM | 4.29% | $37M | 5.42M |
| 6 | SPDR SER TR | NUVEEN BRC MUNIC · PORTFOLIO SHORT | 2.73% | $23M | 471.0K |
| 7 | INVESCO EXCHANGE-TRADED FD T | NATL AMT MUNI | 2.39% | $20M | 790.3K |
| 8 | ERIEURELDORADO RESORTS INChistory → | COM | 1.80% | $15M | 1.07M |
| 9 | PDLIEURPDL BIOPHARMA INChistory → | COM | 1.62% | $14M | 4.90M |
| 10 | VANECK VECTORS ETF TR | AMT FREE INT ETF | 1.32% | $11M | 230.1K |
| 11 | CMLSQCUMULUS MEDIA INChistory → | COM CLASS A | 1.14% | $10M | 1.79M |
| 12 | MRMONTAGE RES CORP | COM | 0.60% | $5M | 2.28M |
| 13 | PENN VA CORP | COM | 0.37% | $3M | 1.01M |
| 14 | MDREURMCDERMOTT INTL INC | COM | 0.00% | $4,000 | 63.0K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $1.3B | 16 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $2.2B | 21 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $1.9B | 23 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $1.4B | 16 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $1.3B | 14 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $1.2B | 12 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $1.5B | 11 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $1.8B | 15 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $1.7B | 14 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $1.1B | 11 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $1.8B | 16 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $2.2B | 8 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $1.2B | 10 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $1.3B | 9 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $1.4B | 10 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $1.3B | 9 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $2.0B | 14 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $1.8B | 13 | Feb 18, 2022 | RESTATEMENT | changes · EDGAR ↗ |
| Q3 2021 | $2.1B | 12 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $1.8B | 13 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $948M | 12 | May 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $862M | 11 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $820M | 12 | Nov 16, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $709M | 9 | Aug 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $853M | 18 | May 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $1.3B | 11 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $2.6B | 14 | Nov 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $805M | 10 | Aug 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $711M | 12 | May 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $691M | 14 | Feb 14, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.